Free Trial

Sanara MedTech (SMTI) Competitors

Sanara MedTech logo
$38.10 +0.38 (+1.01%)
As of 12:19 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SMTI vs. LQDA, EMBC, PLSE, ESTA, FNA, EYE, BVS, AXGN, BFLY, and CBLL

Should you be buying Sanara MedTech stock or one of its competitors? The main competitors of Sanara MedTech include Liquidia (LQDA), Embecta (EMBC), Pulse Biosciences (PLSE), Establishment Labs (ESTA), Paragon 28 (FNA), National Vision (EYE), Bioventus (BVS), AxoGen (AXGN), Butterfly Network (BFLY), and CeriBell (CBLL). These companies are all part of the "medical equipment" industry.

Sanara MedTech vs.

Liquidia (NASDAQ:LQDA) and Sanara MedTech (NASDAQ:SMTI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, community ranking, media sentiment, risk, profitability, earnings and institutional ownership.

Liquidia has a beta of 0.23, meaning that its stock price is 77% less volatile than the S&P 500. Comparatively, Sanara MedTech has a beta of 1.55, meaning that its stock price is 55% more volatile than the S&P 500.

In the previous week, Sanara MedTech had 12 more articles in the media than Liquidia. MarketBeat recorded 14 mentions for Sanara MedTech and 2 mentions for Liquidia. Liquidia's average media sentiment score of 1.25 beat Sanara MedTech's score of 0.45 indicating that Liquidia is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Liquidia
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Sanara MedTech
2 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Liquidia currently has a consensus target price of $25.38, suggesting a potential upside of 83.46%. Sanara MedTech has a consensus target price of $47.00, suggesting a potential upside of 24.92%. Given Liquidia's stronger consensus rating and higher possible upside, research analysts clearly believe Liquidia is more favorable than Sanara MedTech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Liquidia
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.11
Sanara MedTech
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Sanara MedTech has higher revenue and earnings than Liquidia. Sanara MedTech is trading at a lower price-to-earnings ratio than Liquidia, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Liquidia$17.49M66.93-$78.50M-$1.63-8.49
Sanara MedTech$64.99M5.06-$4.30M-$0.99-38.01

Liquidia received 181 more outperform votes than Sanara MedTech when rated by MarketBeat users. Likewise, 68.24% of users gave Liquidia an outperform vote while only 58.33% of users gave Sanara MedTech an outperform vote.

CompanyUnderperformOutperform
LiquidiaOutperform Votes
202
68.24%
Underperform Votes
94
31.76%
Sanara MedTechOutperform Votes
21
58.33%
Underperform Votes
15
41.67%

Sanara MedTech has a net margin of -10.71% compared to Liquidia's net margin of -765.38%. Sanara MedTech's return on equity of -19.86% beat Liquidia's return on equity.

Company Net Margins Return on Equity Return on Assets
Liquidia-765.38% -163.21% -67.14%
Sanara MedTech -10.71%-19.86%-10.91%

64.5% of Liquidia shares are held by institutional investors. Comparatively, 8.1% of Sanara MedTech shares are held by institutional investors. 30.1% of Liquidia shares are held by company insiders. Comparatively, 54.1% of Sanara MedTech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Liquidia beats Sanara MedTech on 10 of the 19 factors compared between the two stocks.

Get Sanara MedTech News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMTI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMTI vs. The Competition

MetricSanara MedTechSurgical appliances & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$330.15M$10.47B$5.42B$9.21B
Dividend YieldN/A1.33%5.36%3.97%
P/E Ratio-38.1618.8286.7517.45
Price / Sales5.0626.481,296.9978.84
Price / CashN/A23.5444.6537.70
Price / Book7.216.024.984.68
Net Income-$4.30M$177.36M$117.81M$224.54M
7 Day Performance15.03%3.90%1.78%1.13%
1 Month Performance10.30%10.96%3.16%3.88%
1 Year Performance7.16%-0.98%25.83%21.57%

Sanara MedTech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMTI
Sanara MedTech
1.3119 of 5 stars
$38.10
+1.0%
$47.00
+23.4%
+6.8%$332.99M$64.99M-38.4860Analyst Forecast
Analyst Revision
News Coverage
LQDA
Liquidia
2.8423 of 5 stars
$12.89
+3.0%
$25.38
+96.9%
+7.1%$1.09B$17.49M-7.9150Positive News
EMBC
Embecta
3.5459 of 5 stars
$18.68
-0.7%
$23.00
+23.1%
+10.4%$1.09B$1.12B13.842,100News Coverage
Gap Up
PLSE
Pulse Biosciences
1.7227 of 5 stars
$17.61
-0.2%
N/A+99.8%$1.08B$700,000.000.00140Gap Down
ESTA
Establishment Labs
1.8101 of 5 stars
$34.56
-0.2%
$60.60
+75.3%
-3.6%$967.68M$165.15M-13.40960
FNA
Paragon 28
3.1778 of 5 stars
$10.85
+1.8%
$15.60
+43.7%
-1.5%$908.61M$216.39M-14.67343,000Gap Up
EYE
National Vision
2.6413 of 5 stars
$10.80
+0.5%
$13.50
+25.0%
-43.6%$850.50M$2.13B-54.0013,998Analyst Forecast
Analyst Revision
High Trading Volume
BVS
Bioventus
3.5524 of 5 stars
$10.04
-0.7%
$15.00
+49.4%
+109.8%$814.75M$512.34M-16.461,200
AXGN
AxoGen
1.2906 of 5 stars
$18.09
-1.8%
$16.00
-11.6%
+109.0%$796.11M$180.86M-56.53450Analyst Revision
Positive News
BFLY
Butterfly Network
1.0029 of 5 stars
$3.67
-5.4%
$3.00
-18.3%
+262.5%$782.14M$65.90M-7.98460
CBLL
CeriBell
N/A$21.04
+4.4%
$32.60
+54.9%
N/A$753.74M$60.04M0.00N/A

Related Companies and Tools


This page (NASDAQ:SMTI) was last updated on 1/23/2025 by MarketBeat.com Staff
From Our Partners